Earnings Call · Q3 FY2021·2021-11-10

Q3 21EPS -11.11%·Rev n/aQ2 21EPS +14.06%·Rev n/aQ1 21EPS -13.37%·Rev n/aQ4 20EPS n/a·Rev n/a⚠ consensus missing

Clearside Biomedical, Inc. CLSDQ

Jenny Kobin — Investor Relations

George Lasezkay — Chief Executive Officer

Thomas Ciulla — Chief Medical Officer

Charlie Deignan — Chief Financial Officer

−3.1%1d on move date−2.3% vs SPY3d−4.3%5d−8.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CLSDQ calls or request research access.

More CLSDQ calls Browse calls Request research access